- Home
- CPRI vs SRPT Comparison
CPRI vs SRPT Comparison
Compare CPRI & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRI
- SRPT
- Stock Information
- Founded
- CPRI 1981
- SRPT 1980
- Country
- CPRI United Kingdom
- SRPT United States
- Employees
- CPRI N/A
- SRPT N/A
- Industry
- CPRI Apparel
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- CPRI Consumer Discretionary
- SRPT Health Care
- Exchange
- CPRI Nasdaq
- SRPT Nasdaq
- Market Cap
- CPRI 2.2B
- SRPT 1.9B
- IPO Year
- CPRI 2011
- SRPT 1997
- Fundamental
- Price
- CPRI $22.32
- SRPT $22.83
- Analyst Decision
- CPRI Buy
- SRPT Hold
- Analyst Count
- CPRI 12
- SRPT 30
- Target Price
- CPRI $24.08
- SRPT $36.56
- AVG Volume (30 Days)
- CPRI 2.0M
- SRPT 5.6M
- Earning Date
- CPRI 11-07-2025
- SRPT 11-05-2025
- Dividend Yield
- CPRI N/A
- SRPT N/A
- EPS Growth
- CPRI N/A
- SRPT N/A
- EPS
- CPRI N/A
- SRPT N/A
- Revenue
- CPRI $4,391,000,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- CPRI N/A
- SRPT $9.68
- Revenue Next Year
- CPRI $3.83
- SRPT N/A
- P/E Ratio
- CPRI N/A
- SRPT N/A
- Revenue Growth
- CPRI N/A
- SRPT 64.89
- 52 Week Low
- CPRI $11.86
- SRPT $10.42
- 52 Week High
- CPRI $42.21
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- CPRI 60.71
- SRPT 57.49
- Support Level
- CPRI $18.85
- SRPT $21.29
- Resistance Level
- CPRI $22.98
- SRPT $23.72
- Average True Range (ATR)
- CPRI 0.86
- SRPT 1.23
- MACD
- CPRI 0.24
- SRPT -0.09
- Stochastic Oscillator
- CPRI 85.84
- SRPT 44.81
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. Capri also owns a third brand, Versace, but has agreed to sell it to Prada. John Idol has served as Capri's CEO since 2003.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.